Simplify Logo

Full-Time

Director – Clinical Operations

Confirmed live in the last 24 hours

Tango Therapeutics

Tango Therapeutics

51-200 employees

Develops targeted cancer therapies using synthetic lethality

Data & Analytics
Hardware
Biotechnology
Healthcare

Senior, Expert

Boston, MA, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Communications
PowerPoint/Keynote/Slides
Requirements
  • BA/BS preferably in nursing, biology, biochemistry or related area (advanced degree desired), with at least 12 years of experience in clinical research operations
  • Minimum of 2 years of oncology experience required, 5+ years preferred
  • Biotechnology experience required
  • Early phase experience, including IND submissions, required
  • Strong vendor management and project management skills are critical
  • Excellent written and oral communication skills
  • Strong working knowledge of GCP/ICH and other applicable regulations/guidelines, required
  • Good organizational/prioritization skills with strong attention to detail
  • Working knowledge of oversight requirements and an eye for quality, required
  • Strong proficiency with MS Office programs such as Outlook, Word, Excel, PowerPoint, and SharePoint, required
  • Collaborative spirit for working positively and effectively with cross-functional teams and partners is essential
  • Travel of up to 25% required
Responsibilities
  • You will oversee the development of clinical trial project timelines and ensure communication and understanding of risks and challenges; establish plans and monitor metrics; ensure that timelines are accurate and comprehensive
  • Work cross-functionally to coordinate the relevant and timely exchange of information and materials to support clinical trial deliverables
  • Manage clinical trials from start-up through close-out to ensure that both internal and external deliverables are on time and on budget while collaborating across functional areas
  • Proactively manage clinical trial outsourced partners, including identification of risk, to ensure trial deliverables and performance goals are met
  • Maintain partnerships and positive and productive relationships with CRO counterparts; proactively review and identify potential issues or problems with the sites and communicate/escalate to clinical leadership
  • Collaborate with CROs to keep the clinical study database current, accurate, and routinely cleaned
  • Manage the scope of work, change notifications, contract modification, site trial agreements, and other necessary budgetary information for clinical trial operations
  • Support and manage oversight activities of all necessary vendors to ensure a high level of operational excellence is maintained
  • Additional duties and responsibilities as required

Tango Therapeutics develops targeted cancer treatments using the principle of synthetic lethality, which allows them to design drugs that kill cancer cells while leaving healthy cells unharmed. Their approach focuses on the interaction between genes, where the loss of both genes leads to cell death, but the loss of just one does not. This method enables them to create more effective therapies for cancer patients. Tango operates in the oncology market, primarily serving healthcare providers and pharmaceutical companies. They collaborate with larger firms, like Gilead Sciences, to co-develop therapies, which helps them secure funding and speed up the development process. Their goal is to bring next-generation targeted immunotherapies to market, supported by a strong team and strategic partnerships.

Company Stage

IPO

Total Funding

$537M

Headquarters

Cambridge, Massachusetts

Founded

2017

Growth & Insights
Headcount

6 month growth

8%

1 year growth

23%

2 year growth

84%
Simplify Jobs

Simplify's Take

What believers are saying

  • Tango's recent $80 million private placement financing strengthens their financial position and supports ongoing R&D efforts.
  • The company's ability to secure Orphan Drug Designation and Fast Track Designation for their therapies highlights their potential to bring innovative treatments to market quickly.
  • Participation in high-profile investor conferences and scientific meetings enhances Tango's visibility and credibility in the biotech community.

What critics are saying

  • The discontinuation of the TNG348 program due to liver toxicity raises concerns about the safety and viability of their drug candidates.
  • The highly competitive oncology market requires continuous innovation and successful clinical trials to maintain a leading position.

What makes Tango Therapeutics unique

  • Tango Therapeutics leverages the principle of synthetic lethality to develop cancer treatments, a unique approach that specifically targets cancer cells while sparing healthy ones.
  • Their strategic collaborations with larger pharmaceutical companies like Gilead Sciences provide financial support and accelerate the development and commercialization of their therapies.
  • Tango's robust pipeline and focus on precision oncology, including targeting MTAP-deleted solid tumors and BRCA1/2 mutations, set them apart in the oncology market.